Please try another search
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Name | Age | Since | Title |
---|---|---|---|
Neil Harris Cohen | 58 | 2020 | Independent Director |
Alan Charles Moses | 74 | 2021 | Independent Director |
Arun J. Sanyal | - | - | Member of Scientific Advisory Board |
Nissim Darvish | 59 | 2021 | Independent Chairman |
Massimo Pinzani | - | - | Member of Scientific Advisory Board |
Claude Nicaise | 70 | 2021 | Independent Director |
Adi Mor George | 41 | 2011 | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Jill M. Quigley | 47 | 2022 | Independent Director |
Jacob George | - | - | Member of Scientific Advisory Board |
Dinesh Khanna | - | - | Member of Scientific Advisory Board |
Francesco Del Galdo | - | - | Member of Scientific Advisory Board |
Marco Matucci-Cerinic | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review